| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.049 | 0.3 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.033 | 0.3 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.052 | 0.3 |
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.038 | 0.3 |